(Q36642800)

15 August 2017

0 references

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients (English)

1 reference

15 August 2017

1 reference

1 reference

1 reference

1 reference

Fabrizi F

1

1 reference

15 August 2017

Lunghi G

series ordinal

2

1 reference

15 August 2017

Dixit V

series ordinal

3

1 reference

15 August 2017

Martin P

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Alimentary Pharmacology & Therapeutics

15 August 2017

published in

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1413-1422

1 reference

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Amantadine therapy in renal transplant patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Approaches to heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Hepatitis C, interferon, and risk of rejection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03151.X

10.1111/J.1365-2036.2006.03151.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference